Key points are not available for this paper at this time.
Patients with primary FSGS and IgM and C3 deposition showed unfavorable therapeutic responses and worse renal outcomes, which indicate that IgM and C3 deposition might involve disease progression via complement activation.
Zhang et al. (Thu,) studied this question.